Harald Rieder

5.7k total citations · 1 hit paper
84 papers, 3.5k citations indexed

About

Harald Rieder is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Harald Rieder has authored 84 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 28 papers in Public Health, Environmental and Occupational Health and 24 papers in Molecular Biology. Recurrent topics in Harald Rieder's work include Acute Lymphoblastic Leukemia research (27 papers), Chronic Myeloid Leukemia Treatments (21 papers) and Acute Myeloid Leukemia Research (15 papers). Harald Rieder is often cited by papers focused on Acute Lymphoblastic Leukemia research (27 papers), Chronic Myeloid Leukemia Treatments (21 papers) and Acute Myeloid Leukemia Research (15 papers). Harald Rieder collaborates with scholars based in Germany, Austria and United States. Harald Rieder's co-authors include Christa Fonatsch, Detlef K. Bartsch, Guido Hartmann, K. Michael Weidner, T Hishida, Yasushi Daikuhara, N Arakaki, Stefan Schwartz, Nicola Gökbuget and Hirohito Tsubouchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Bioinformatics.

In The Last Decade

Harald Rieder

83 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for the identity of human scatter factor and human hepatocyte growth factor.

1991 562 citations K. Michael Weidner, N Arakaki et al. profile →

Peers

Countries citing papers authored by Harald Rieder

Since Specialization

Citations

This map shows the geographic impact of Harald Rieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Rieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Rieder more than expected).

Fields of papers citing papers by Harald Rieder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Rieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Rieder. The network helps show where Harald Rieder may publish in the future.

Co-authorship network of co-authors of Harald Rieder

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Rieder. A scholar is included among the top collaborators of Harald Rieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Rieder. Harald Rieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines 2019 ·Scientific Reports ·Margaretha A. Skowron, Patrick Petzsch, Karin Hardt, Nicholas Wagner, Manfred Beier, Stefanie Stepanow, Matthias Drechsler, Harald Rieder, Karl Köhrer, Günter Niegisch, Michèle J. Hoffmann, Wolfgang A. Schulz	10
2	The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors 2016 ·Bladder Cancer ·Michèle J. Hoffmann, (unknown), Margaretha A. Skowron, Maria Pinkerneil, Günter Niegisch, (unknown), Stefanie Stepanow, Harald Rieder, Wolfgang A. Schulz	38
3	Involvement of the MLL gene in adult T‐lymphoblastic leukemia 2012 ·Genes Chromosomes and Cancer ·Seval Türkmen, Bernd Timmermann, (unknown), Daniela Gröger, Claus Meyer, Stefan Schwartz, Claudia Haferlach, Harald Rieder, Nicola Gökbuget, Dieter Hoelzer, Rolf Marschalek, Thomas Burmeister	10
4	Molecular analysis of the t(2;8)/MYC–IGK translocation in high‐grade lymphoma/leukemia by long‐distance inverse PCR 2011 ·Genes Chromosomes and Cancer ·(unknown), Stefan Schwartz, Richard Reinhardt, Harald Rieder, Mara Molkentin, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel, Thomas Burmeister	6
5	Low Frequency of CHEK2 Mutations in Familial Pancreatic Cancer 2006 ·Familial Cancer ·Detlef K. Bartsch, (unknown), Mercedes Sina‐Frey, Volker Fendrich, Harald Rieder, Peter Langer, R. Kress, (unknown), Stephan A. Hahn, Emily P. Slater	28
6	Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features 2005 ·Leukemia ·Thomas Burmeister, Stefan Schwartz, (unknown), Harald Rieder, Nicola Gökbuget, D. Hoelzer, E. Thiel	37
7	Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma 2005 ·Oncogene ·Corinna Grasemann, (unknown), Harald Stephan, Andreas Schüler, Alexander Schramm, Ludger Klein‐Hitpaß, Harald Rieder, Stephanie Schneider, Ferdinand Kappes, Angelika Eggert, Dietmar Lohmann	89
8	RNASEL germline variants are associated with pancreatic cancer 2005 ·International Journal of Cancer ·Detlef K. Bartsch, Volker Fendrich, Emily P. Slater, Mercedes Sina‐Frey, Harald Rieder, William Greenhalf, Brunhilde Chaloupka, Stephan A. Hahn, John P. Neoptolemos, R. Kress	37
9	CyDAS: a cytogenetic data analysis system 2004 ·Bioinformatics ·(unknown), Jutta Bradtke, (unknown), Harald Rieder	39
10	No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma 2004 ·Cancer Letters ·Robert Grützmann, Christopher McFaul, Detlef K. Bartsch, Mercedes Sina‐Frey, Harald Rieder, Rainer Koch, (unknown), William Greenhalf, John P. Neoptolemos, H. D. Saeger, Christian Pilarsky	20
11	Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10−/CD24−/CD65s+/CD15+ B-cell phenotype 2003 ·Leukemia ·Stefan Schwartz, Harald Rieder, (unknown), Thomas Burmeister, L. Fischer, E. Thiel	75
12	Molecular and chromosomal mechanisms of resistance in CML patients after STI571 (Glivec) therapy 2001 ·ePrints Soton (University of Southampton) ·Sebastian Kreil, Martin Müller, Tanja Lahaye, Paul La Rosée, A. Corbin, Claudia Schoch, Nicholas C.P. Cross, Ute Berger, Harald Rieder, Brian Druker, Harald Gschaidmeier, R. Hehlmann, Andreas Hochhaus	16
13	Distinction of eosinophilic leukaemia from idiopathic hypereosinophilic syndrome by analysis of Wilms' tumour gene expression 1998 ·British Journal of Haematology ·(unknown), (unknown), Harald Rieder, (unknown), Alexander Schmidt, Michael Notter, (unknown)	22
14	Loss of Heterozygosity of the Retinoblastoma (RB1) Gene in Lipomas From a Retinoblastoma Patient 1998 ·JNCI Journal of the National Cancer Institute ·Harald Rieder, (unknown), Bárbara Fritz, (unknown), (unknown), Helga Rehder, Dietmar Lohmann, (unknown)	11
15	High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia 1998 ·Leukemia ·Harald Rieder, (unknown), (unknown), J. Mäurer, (unknown), Stefan Schwartz, W-D Ludwig, W. Gaßmann, (unknown), E. Thiel, H. Löffler, Nicola Gökbuget, D. Hoelzer, Christa Fonatsch	29
16	The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients 1998 ·Leukemia ·Anthony V. Moorman, A Hagemeijer, C Charrin, Harald Rieder, LM Secker-Walker	73
17	Morphological and cytochemical findings in 150 cases of T‐lineage acute lymphoblastic leukaemia in adults 1997 ·British Journal of Haematology ·W. Gaßmann, Helmut Löffler, E. Thiel, Wolfgang Ludwig, Stefan Schwartz, Torsten Haferlach, Jürgen Mäurer, Harald Rieder, Christa Fonatsch, Nicola Gökbuget, Dieter Hoelzer	21
18	Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia 1996 ·British Journal of Haematology ·Harald Rieder, Wolfgang Ludwig, W. Gaßmann, Jürgen Mäurer, Johannes W.G. Janssen, Nicola Gökbuget, Stefan Schwartz, Eckhard Thiel, Helmut Löffler, Claus R. Bartram, Dieter Hoelzer, Christa Fonatsch	62
19	The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event 1995 ·British Journal of Haematology ·Johannes W.G. Janssen, Susan A. Ridge, (unknown), Finbarr E. Cotter, (unknown), (unknown), Harald Rieder, Wolfram Ostertag, Claus R. Bartram, Leanne M. Wiedemann	41
20	Evidence for the identy of human scatter factor and human hepatocyte growth factor. 1991 ·Ghent University Academic Bibliography (Ghent University) ·K. Michael Weidner, N Arakaki, Guido Hartmann, Joël Vandekerckhove, (unknown), Harald Rieder, Christa Fonatsch, H Tsubouchi, T Hishida, Yasushi Daikuhara, Walter Birchmeier	153

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact